WHO AWaRe classification | Antibiotic agents | Frequency | Percentage |
---|---|---|---|
Access(n = 419) | |||
Penicillin | 209 | 49.9% | |
Ampicillin/sulbactam | 85 | 20.3% | |
Amoxicillin/clavulanic acid | 50 | 11.9% | |
Metronidazole | 24 | 5.7% | |
Ampicillin | 13 | 3.1% | |
Cefazolin | 11 | 2.6% | |
Flucloxacillin | 9 | 2.1% | |
Amoxicillin | 6 | 1.4% | |
Amikacin | 3 | 0.7% | |
Cefathiamidine | 3 | 0.7% | |
Cloxacillin | 2 | 0.5% | |
Ornidazole | 2 | 0.5% | |
Oxacillin | 1 | 0.2% | |
Chloramphenicol | 1 | 0.2% | |
Watch(n = 1343) | |||
Meropenem | 229 | 17.1% | |
Latamoxef | 192 | 14.3% | |
Ceftizoxime | 184 | 13.7% | |
Ceftazidime | 135 | 10.1% | |
Cefotaxime | 112 | 8.3% | |
Piperacillin/tazobactam | 87 | 6.5% | |
Vancomycin | 73 | 5.4% | |
Imipenem/cilastin | 61 | 4.5% | |
Erythromycin | 59 | 4.4% | |
Ceftriaxone | 45 | 3.4% | |
Cefmenoxime | 40 | 3.0% | |
Cefuroxime | 39 | 2.9% | |
Cefepime | 25 | 1.9% | |
Teicoplanin | 21 | 1.6% | |
Piperacillin | 14 | 1.0% | |
Azithromycin | 10 | 0.7% | |
Cefotiam | 3 | 0.2% | |
Panipenem/betamipron | 2 | 0.1% | |
Ticarcillin | 2 | 0.1% | |
Cefaclor | 2 | 0.1% | |
Cefoperazone | 2 | 0.1% | |
Levofloxacin | 2 | 0.1% | |
Ertapenem | 1 | 0.1% | |
Mezlocillin | 1 | 0.1% | |
Cefdinir | 1 | 0.1% | |
Cefixime | 1 | 0.1% | |
Reserve(n = 6) | |||
Linezolid | 4 | 66.7% | |
Aztreonam | 2 | 33.3% | |
Not recommended(n = 174) | |||
Cefoperazone/sulbactam | 127 | 73.0% | |
Amoxicillin/sulbactam | 36 | 20.7% | |
Mezlocillin/sulbactam | 11 | 6.3% | |
Unclassified(n = 1) | |||
Ticarcillin/enzyme inhibitor | 1 | 100% |